Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-08-16

FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Biltricide (praziquantel) filed by Bayer HealthCare Pharmaceuticals Inc., updating the product's labeling and/or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BILTRICIDE (praziquantel)

Snippet

SUPPL AP for BILTRICIDE (PRAZIQUANTEL)